Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at Barclays Global Consumer Staples Conference (Virtual) Transcript

Sep 08, 2020 / 05:20PM GMT
Release Date Price: €125.64 (-1.66%)
Lauren Rae Lieberman
Barclays Bank PLC, Research Division - MD & Senior Research Analyst

So for our next presentation, we have Johnson & Johnson Consumer Health. Presenting, we have Thibaut Mongon, Executive Vice President and Worldwide Chairman for Consumer Health. We're going to start out with some prepared remarks and then a Q&A session that I'll moderate. So let's just jump right in. Over to you, Thibaut.

Thibaut Mongon
Johnson & Johnson - Executive VP & Worldwide Chairman of Consumer Health

Thank you, Lauren, and good afternoon, everyone. It's great to be back here, even if it's virtually this year, but it's always a pleasure to be at Barclays and having an opportunity to give all of you an update on Johnson & Johnson Consumer Health. So before we get started, let me remind you that this presentation may contain forward-looking statements. So I encourage you to really refer to our SEC filings, all of them are available to you online.

So before we get started, let me remind you where we stand, Johnson & Johnson, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot